NCT03262584View on ClinicalTrials.gov

Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

September 28, 2018

Conditions

Invasive Fungal DiseaseFever and NeutropeniaInvasive Fungal InfectionsImmunocompromised

Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors

collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

lead

Karius, Inc.

INDUSTRY

NCT03262584 - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients | Biotech Hunter | Biotech Hunter